Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octenisept versus Ringer solution for chronic venous leg ulcer healing
2006-001855-37Phase 3Terminated
- Sponsor
- Schülke & Mayr
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of octenidine dihydrochloride + phenoxyethanol in stasis ulcer and venous stasis (2 arms), sponsored by Schülke & Mayr. Primary endpoint: Time to complete wound closure of the target ulcer. Started Feb 2007; status: terminated.
02
Drugs
octenidine dihydrochloride + phenoxyethanol
03
Conditions
stasis ulcervenous stasis
Beyond the preview
Go deeper on 2006-001855-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001855-37.